ProQR Therapeutics N.V.
PRQR
|
News
|
$2.0
-0.99%
-1.0%
36K
|
Health Technology
(0.0% 1d) (-16.3% 1m) (-9.0% 1y) (0.0% 2d) (-0.5% 3d) (1.0% 7d) (-80.37% volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 162,709,184
http://www.proqr.com
Sec Filling | Patents | 154 employees
ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.
fibrosis genetic msa treatment
add to watch list Paper trade email alert is off
Press-releases
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 0.5%
H: 5.47%
C: 0.5%
meeting
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 0.5%
H: 5.47%
C: 0.5%
meeting
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: -1.04%
H: 8.95%
C: 4.74%
defense
ProQR Announces Year End 2023 Operating and Financial Results
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: -1.46%
H: 21.78%
C: 15.35%
year financial results
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
Published: 2024-02-15 (Crawled : 12:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 0.52%
H: 7.73%
C: 0.52%
patent
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Published: 2024-01-19 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: 0.99%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 2.36%
H: 2.76%
C: -4.15%
presentation technology platform
ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
Published: 2024-01-05 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 1.5%
H: 1.48%
C: -0.25%
research collaboration trust
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
Published: 2023-12-08 (Crawled : 12:30) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 0.49%
H: 3.9%
C: -2.44%
acquire therapeutics
ProQR Announces Third Quarter 2023 Operating and Financial Results
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 4.2%
H: 0.83%
C: 0.49%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: -2.46%
H: 21.85%
C: 13.45%
financial results
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 1.65%
H: 4.07%
C: -0.81%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10